Olfactory loss is an early and reliable marker for COVID-19
View ORCID ProfileBehzad Iravani, View ORCID ProfileArtin Arshamian, View ORCID ProfileJohan N. Lundström
doi: https://doi.org/10.1101/2022.02.23.22271409
Behzad Iravani
1Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
Artin Arshamian
1Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
2Department of Psychology, Stockholm University, Stockholm, Sweden
Johan N. Lundström
1Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
3Stockholm University Brain Imaging Center, Stockholm University, Stockholm, Sweden
4Monell Chemical Senses Center, Philadelphia, Pennsylvania, US
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted February 24, 2022.
Olfactory loss is an early and reliable marker for COVID-19
Behzad Iravani, Artin Arshamian, Johan N. Lundström
medRxiv 2022.02.23.22271409; doi: https://doi.org/10.1101/2022.02.23.22271409
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)